Tags:
EU HTA, Health Technology Assessment, European Launch Strategy, Market Access Intelligence, Competitive Intelligence, Pharmaceutical Market Access, AI in Pharma
AI-powered Continuous Intelligence is transforming European Launch Strategy by helping pharmaceutical teams prepare for EU HTA, optimize reimbursement planning, and monitor competitor activity in real time. This case study shows how Market Access Intelligence supports stronger evidence generation, better payer engagement, and more informed commercialization decisions across Europe's evolving healthcare landscape.




